Browse our anti-LARS (LARS) Antibodies

Full name:
anti-Leucyl-tRNA Synthetase Antibodies (LARS)
On are 26 Leucyl-tRNA Synthetase (LARS) Antibodies from 11 different suppliers available. Additionally we are shipping LARS Proteins (3) and many more products for this protein. A total of 32 LARS products are currently listed.
2310045K21Rik, 3110009L02Rik, AA591035, AW536573, BA4991, CG7479, DDBDRAFT_0183834, DDBDRAFT_0231251, DDB_0183834, DDB_0231251, Dmel\\CG7479, F21M12.1, F21M12_1, hr025Cl, HSPC192, LAR, LARS, LARS1, LEURS, LEUS, LRS, mKIAA1352, PIG44, RNTLS, RPTP-LAR
list all antibodies Gene Name GeneID UniProt
LARS 51520 Q9P2J5
LARS 107045 Q8BMJ2
LARS 291624  

Show all species

Show all synonyms

Most Popular Reactivities for anti-LARS (LARS) Antibodies

Select your species and application

anti-Human LARS Antibodies:

anti-Mouse (Murine) LARS Antibodies:

anti-Rat (Rattus) LARS Antibodies:

All available anti-LARS Antibodies

Go to our pre-filtered search.

Top referenced anti-LARS Antibodies

  1. Human Polyclonal LARS Primary Antibody for EIA, FACS - ABIN953139 : Pang, Martinis: A paradigm shift for the amino acid editing mechanism of human cytoplasmic leucyl-tRNA synthetase. in Biochemistry 2009 (PubMed)
    Show all 4 references for 953139

  2. Human Polyclonal LARS Primary Antibody for IHC (p), WB - ABIN391611 : Lue, Kelley: A single residue in leucyl-tRNA synthetase affecting amino acid specificity and tRNA aminoacylation. in Biochemistry 2007 (PubMed)
    Show all 3 references for 391611

  3. Human Polyclonal LARS Primary Antibody for EIA, IHC (p) - ABIN359572 : Ling, Yao, Zheng, Wei, Wang, Wu, Wang: The C-terminal appended domain of human cytosolic leucyl-tRNA synthetase is indispensable in its interaction with arginyl-tRNA synthetase in the multi-tRNA synthetase complex. in The Journal of biological chemistry 2005 (PubMed)
    Show all 3 references for 359572

More Antibodies against LARS Interaction Partners

Human Leucyl-tRNA Synthetase (LARS) interaction partners

  1. the KMSKS catalytic loop affects the aminoacylation and editing capacities of leucyl-tRNA synthetase (show LARS2 Antibodies)

  2. Lack of a CP1 (show PCBP1 Antibodies) hairpin in LeuRS (show LARS2 Antibodies) led to complete loss of aminoacylation, amino acid activation, and tRNA binding; however, the mutants retained post-transfer editing.

  3. the carboxy-terminal domain of human mitochondrial (mt) leucyl-tRNA synthetase (show LARS2 Antibodies) can be used to correct mt dysfunctions caused by mt-tRNA mutations.

  4. Identification of a mutation in LARS as a novel cause of infantile hepatopathy

  5. This work demonstrates that LRS is a key mediator for amino acid signaling to mTORC1.

  6. leucyl-tRNA synthetase (show LARS2 Antibodies) requires its C-terminal domain for its interaction with arginyl-tRNA synthetase (show RARS Antibodies) in the multi-tRNA synthetase complex

  7. Results show that K600 in human leucyl-tRNA synthetase (show LARS2 Antibodies) affects amino acid specificity and tRNA aminoacylation.

  8. findings suggest that LARS1 may play roles in migration and growth of lung cancer cells, which suggest its potential implication in lung tumorigenesis

  9. Study of crystal structures of the editing domain from 2 eukaryotic cytosolic LeuRS (show LARS2 Antibodies); shows a conserved structural core containing the active site for hydrolysis, with distinct bacterial, archeal, or eukaryotic peripheral insertions.

Mouse (Murine) Leucyl-tRNA Synthetase (LARS) interaction partners

  1. loss of LAR (show PTPRF Antibodies) activity resulted in reduced activity of CDK1 (show CDK1 Antibodies).

  2. Study has identified LAR (show PTPRF Antibodies) as a regulator of key signaling pathways, including mTOR (show FRAP1 Antibodies) and JNK (show MAPK8 Antibodies), and has significantly expanded the number of proteins regulated downstream of LAR (show PTPRF Antibodies) phosphatase activity.

  3. Chondroitin Sulfate Proteoglycans Negatively Modulate Spinal Cord Neural Precursor Cells by Signaling Through LAR (show PTPRF Antibodies) and RPTPsigma (show PTPRS Antibodies) and Modulation of the Rho/ROCK Pathway.

  4. This study demonstrates the crucial role of LAR (show PTPRF Antibodies) in restricting regrowth of injured CNS axons

  5. Ptprs (show PTPRS Antibodies) and Ptprf (show PTPRF Antibodies) deficiency affects mandibular cell proliferation.

  6. Inhibition of LAR (show PTPRF Antibodies) attenuates palmitate-induced insulin (show INS Antibodies) resistance in myotubes.

  7. Deletion of LAR (show PTPRF Antibodies) in knock-out mice or blockade of LAR (show PTPRF Antibodies) with sequence-selective peptides significantly overcomes neurite growth restrictions of chondroitin sulfate proteoglycan (show Vcan Antibodies) in neuronal cultures.

  8. the crystal structures of the first and second immunoglobulin-like domains of the Drosophila type IIa receptor Dlar and its mouse homolog LAR (show PTPRF Antibodies) were reported.

  9. LAR reduces the basal c-Abl activity thereby allowing for platelet derived growth factor beta receptor kinase activation

  10. LAR deficiency affected the differentiation & expansion of immature thymocytes, positive & negative selection, & a lower Ca2+ response. LAR is an important modulator of TCR signaling that controls thymocyte differentiation.

LARS Antigen Profile

Antigen Summary

This gene encodes a cytosolic leucine-tRNA synthetase, a member of the class I aminoacyl-tRNA synthetase family. The encoded enzyme catalyzes the ATP-dependent ligation of L-leucine to tRNA(Leu). It is found in the cytoplasm as part of a multisynthetase complex and interacts with the arginine tRNA synthetase through its C-terminal domain. Alternatively spliced transcript variants of this gene have been found\; however, their full-length nature is not known.

Alternative names and synonyms associated with LARS

  • Leucyl-tRNA synthetase (Aats-leu) antibody
  • ATP binding/leucine-tRNA ligases/aminoacyl-tRNA ligases (AT1G09620) antibody
  • leucyl-tRNA synthetase (leuS) antibody
  • leucine-tRNA ligase (mleuS) antibody
  • leucyl-tRNA synthetase (LARS) antibody
  • leucyl-tRNA synthetase (Lars) antibody
  • protein tyrosine phosphatase, receptor type, F (Ptprf) antibody
  • 2310045K21Rik antibody
  • 3110009L02Rik antibody
  • AA591035 antibody
  • AW536573 antibody
  • BA4991 antibody
  • CG7479 antibody
  • DDBDRAFT_0183834 antibody
  • DDBDRAFT_0231251 antibody
  • DDB_0183834 antibody
  • DDB_0231251 antibody
  • Dmel\\CG7479 antibody
  • F21M12.1 antibody
  • F21M12_1 antibody
  • hr025Cl antibody
  • HSPC192 antibody
  • LAR antibody
  • LARS antibody
  • LARS1 antibody
  • LEURS antibody
  • LEUS antibody
  • LRS antibody
  • mKIAA1352 antibody
  • PIG44 antibody
  • RNTLS antibody
  • RPTP-LAR antibody

Protein level used designations for LARS

Aats-leu-PA , CG7479-PA , leucyl-tRNA synthetase , leucine-tRNA ligase, mitochondrial , leucyl-tRNA synthetase, mitochondrial , cytoplasmic leucyl-tRNA synthetase , cytosolic leucyl-tRNA synthetase , leucine tRNA ligase 1, cytoplasmic , leucine translase , leucine--tRNA ligase, cytoplasmic , leucine-tRNA ligase , leucyl-tRNA synthetase, cytoplasmic , proliferation-inducing gene 44 , leuRS , leukocyte antigen-related (LAR) PTP receptor , leukocyte common antigen related , receptor-type tyrosine-protein phosphatase F

38581 Drosophila melanogaster
837489 Arabidopsis thaliana
1084234 Bacillus anthracis str. Ames
1169003 Shewanella oneidensis MR-1
1208444 Coxiella burnetii RSA 493
2687062 Geobacter sulfurreducens PCA
2798737 Listeria monocytogenes serotype 4b str. F2365
3192670 Ruegeria pomeroyi DSS-3
3230512 Dehalococcoides ethenogenes 195
3231741 Campylobacter jejuni RM1221
3727664 Carboxydothermus hydrogenoformans Z-2901
3927180 Ehrlichia chaffeensis str. Arkansas
3930140 Anaplasma phagocytophilum str. HZ
3931695 Neorickettsia sennetsu str. Miyayama
8628101 Dictyostelium discoideum AX4
51520 Homo sapiens
107045 Mus musculus
291624 Rattus norvegicus
19268 Mus musculus
Selected quality suppliers for anti-LARS (LARS) Antibodies
Did you look for something else?